Literature DB >> 12407184

Exon truncation by alternative splicing of murine ICAM-1.

Joseph P Mizgerd1, Matt R Spieker, Michal M Lupa.   

Abstract

The murine gene for intercellular adhesion molecule-1 (ICAM-1) encodes multiple products, arising from alternative splicing. Full-length ICAM-1 contains five extracellular Ig domains, each encoded by a separate exon. Alternatively spliced forms have Ig domains 2, 3, and/or 4 excised as a result of exon skipping. We report here a novel splice variant of murine ICAM-1, resulting from exon truncation rather than exon skipping and affecting Ig domain 5. A 5' splice donor site within exon 6 generates transcripts missing 69 nucleic acids from the 3' terminus of the exon. This in-frame exon truncation is predicted to replace 24 amino acids within Ig domain 5 with a single aspartic acid residue, yielding a structure other than an Ig domain immediately external to the membrane. Expression of this alternatively spliced form is induced in mouse lungs, spleen, and kidneys during LPS-induced pulmonary inflammation. Since the affected region is critical for ICAM-1 presentation, dimerization, and solubilization, this alternative splice variant may have unique physiological functions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407184     DOI: 10.1152/physiolgenomics.00073.2002

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  3 in total

1.  ICAM-1: isoforms and phenotypes.

Authors:  Theresa N Ramos; Daniel C Bullard; Scott R Barnum
Journal:  J Immunol       Date:  2014-05-15       Impact factor: 5.422

2.  Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis.

Authors:  Bas Heinhuis; Marije I Koenders; Fons A van de Loo; Mihai G Netea; Wim B van den Berg; Leo A B Joosten
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

3.  NF-kappaB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation.

Authors:  Joseph P Mizgerd; Michal M Lupa; Matt S Spieker
Journal:  BMC Immunol       Date:  2004-06-09       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.